Diversified Healthcare Trust (DHC)
NASDAQ: DHC · Real-Time Price · USD
7.02
-0.01 (-0.14%)
Nov 6, 2026, 4:00 PM EST - Market closed
DHC Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,479 | 1,538 | 1,495 | 1,410 | 1,284 | 1,383 |
Revenue Growth | -3.82% | 2.84% | 6.04% | 9.87% | -7.20% | -15.25% |
Net Income Net Income Growth | -152.14 | -285.89 | -370.26 | -293.57 | -15.77 | 174.52 |
Earnings Per Share EPS Growth | -0.63 | -1.19 | -1.55 | -1.23 | -0.07 | 0.73 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Senior Housing Operating Portfolio (SHOP) Senior Housing Operating Portfolio (SHOP) Growth | 1,278 | 1,313 | 1,244 | 1,152 | 1,023 | 974.62 |
Medical Office and Life Science Portfolio Medical Office and Life Science Portfolio Growth | 170.2 | 193.81 | 213.32 | 220.53 | 222.39 | 367.6 |
All Other All Other Growth | 30.42 | 31.39 | 37.72 | 37.87 | 38.35 | 40.99 |
Total Total Growth | 1,479 | 1,538 | 1,495 | 1,410 | 1,284 | 1,383 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 110.71 | 105.41 | 144.58 | 245.94 | 658.07 | 634.85 |
Total Debt Total Debt Growth | 2,421 | 2,418 | 2,931 | 2,841 | 3,075 | 3,681 |
Net Cash (Debt) Net Cash Growth | -2,310 | -2,312 | -2,787 | -2,595 | -2,417 | -3,046 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.59 | -9.62 | -11.63 | -10.86 | -10.14 | -12.80 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 54.01 | -19.62 | 112.22 | 10.48 | -40.35 | -63.32 |
Free Cash Flow Free Cash Flow Growth | 54.01 | -19.62 | 112.22 | 10.48 | -40.35 | -63.32 |
Free Cash Flow Growth | 189.00% | - | 970.52% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Margin | -1.11% | -2.55% | -3.69% | -6.02% | -7.31% | -2.27% |
Pretax Margin | -10.07% | -18.48% | -24.73% | -20.78% | -1.17% | 13.11% |
Profit Margin | -10.29% | -18.59% | -24.76% | -20.82% | -1.23% | 12.62% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.57% | 0.83% | 1.74% | 1.07% | 6.18% | 1.29% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 4.23 |
PS Ratio | 1.15 | 0.76 | 0.37 | 0.64 | 0.12 | 0.53 |